Results 121 to 130 of about 84,438 (207)

Expanding Transposase Technology to Regulatory Noncoding RNAs for Stable Expression in CHO Cells. [PDF]

Biotechnol J
Lochmueller S, Weiss L, Otte K.
europepmc   +1 more source

Intravenously deliverable oncolytic virus VET3-TGI favorably alters the tumor microenvironment. [PDF]

J Immunother Cancer
Zhang M, Barrett K, Carter C, Sampath P, Acosta-Barreto G, Audino S, Moongdee J, Bouchard R, Dunstane D, Matteo N, Biery K, Duyvesteyn E, Cantos M, Brothers KM, Byrd D, Dietrich T, Muthuswamy R, Thorne SH.   +17 more
europepmc   +1 more source

Arming oncolytic Coxsackievirus B3 with Neoleukin-2/15 enhances growth inhibition of colorectal carcinomas and induces T cell activation. [PDF]

Mol Ther Oncol
Elsner L, Girod M, Hazini A, Geisler A, Heimann L, Dieringer B, Shipman-Mueller J, Thiel A, Klopfleisch R, Kurreck J, Van Linthout S, Fechner H.   +11 more
europepmc   +1 more source

Correction to 'Directed evolution of hyperactive integrases for site specific insertion of transgenes'. [PDF]

Nucleic Acids Res
europepmc   +1 more source

The microcephaly protein Abnormal Spindle has an essential role in symmetrically dividing neural precursors to promote brain growth and development. [PDF]

Dev Biol
Chakraborty S, Florez S, Govaerts J, Hawke A, Schoborg T.   +4 more
europepmc   +1 more source

Inducing fixation of transgenic alleles in open-pollinated populations. [PDF]

Transgenic Res
Conner AJ, Jacobs JME.
europepmc   +1 more source

Genetic transformation and genome editing of flax (<i>Linum usitatissimum</i> L.): current status and future perspectives. [PDF]

Front Plant Sci
Mollaev TD, Bruskin SA, Pushkova EN, Dmitriev AA, Melnikova NV.   +4 more
europepmc   +1 more source

Recombinant adenoviruses application for cancer vaccines: from genetic design to clinical translation. [PDF]

Front Oncol
Almarghalani NA, Ganash MA, Alharbi MG, Abualfaraj T, Alkayyal AA, Mahmoud AB.   +5 more
europepmc   +1 more source